Release Date: 02/05/11 13:50 Summary: Update on Additional Exploration Licence Price Sensitive: Yes Download Document 281.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%